The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113

$ 10.00

4.5
(695)
In stock
Description

Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions. - Abstract - Europe PMC

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC

Cells, Free Full-Text

PDF) The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Cells, Free Full-Text

DDC, Free Full-Text

media.springer/full/springer-static/imag

PDF) Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge

Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by

Medicina, Free Full-Text

Medicina, Free Full-Text

PDF) Dissociable effects of dopamine antagonists and cannabinoid

Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats

Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys